Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine
about
Opioid-induced central immune signaling: implications for opioid analgesiaCarbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic painHeroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individualsThe neuroanatomy of sexual dimorphism in opioid analgesia.Evidence for brain glial activation in chronic pain patients.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeFunctionally selective signaling for morphine and fentanyl antinociception and tolerance mediated by the rat periaqueductal gray.Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.Examination of sex and minocycline treatment on acute morphine-induced analgesia and inflammatory gene expression along the pain pathway in Sprague-Dawley rats.Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microgliaMetformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammationSex differences in innate immunity and its impact on opioid pharmacology.Interactions between glia, the immune system and pain processes during early development.Opioid and chemokine receptor crosstalk: a promising target for pain therapy?Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.Opioid adjuvant strategy: improving opioid effectiveness.Selective suppression of microglial activation by paeoniflorin attenuates morphine tolerance.Sex Differences in Microglia Activity within the Periaqueductal Gray of the Rat: A Potential Mechanism Driving the Dimorphic Effects of Morphine.RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain.Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.Delay of morphine tolerance by palmitoylethanolamide.Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia.Glial and neuroinflammatory targets for treating substance use disorders.Increased Central Nervous System Interleukin-8 in a Majority Postlaminectomy Syndrome Chronic Pain Population.Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord.Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation.Inflammasome in drug abuse.Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine.Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling.Pro-inflammatory cytokines, IL-1β and TNF-α, produce persistent compromise in tonic immobility defensive behaviour in endotoxemia guinea-pigs.The dark side of opioids in pain management: basic science explains clinical observation.Chronic morphine treatment increased the expression of myeloid differentiation primary response protein 88 in rat spinal cord.N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.Attenuating the Agent: Reducing Opioid “Virulence”
P2860
Q27021477-4A4C0BD2-A038-481C-8FDB-EE9BA3F7F6E3Q28542981-95D2157C-A70F-43EF-8FBD-D33491BE8DF1Q28545281-9C736906-5376-4D6F-8B9D-99FD58E83032Q34022761-B7E9FCA7-9593-4C45-8BB9-991699C7D3AAQ34457857-55DF24A4-FC92-473D-A722-92738772D07CQ34603199-549D19F2-8D4B-41C0-8B56-04D75EC1ECEDQ34680703-0FA27B9F-EA50-4AB2-A095-3F8678D78DF8Q36064141-B38F0B58-87A5-477A-81EB-9BF1B7B1BDB4Q36365976-C23D1D92-B361-45C8-9729-3E364184D264Q36453875-09E7B817-5C9B-43CC-8D2C-DE414FEEBA3AQ36639446-FB54FEC8-D49D-4830-A7D5-A8B38B3481D0Q37422131-9616770E-CDDB-49AD-BCD8-B673E27BF5BAQ37432134-3B715DCA-840F-477B-A268-DD8B1834EDE7Q38218630-829B034C-6447-48D4-BB67-4D146A02659BQ38318330-54F8A0FF-24A8-48C9-B8E4-E636483A1FFBQ38542687-2F2AE994-EDA6-4401-A656-90A817081DEDQ38742586-E51DF7E3-D25F-4ED5-ABA0-D082ACE637EBQ38940193-0E951603-7E74-4838-AB1A-CB1DD2597250Q38951157-B3658854-733F-4E5A-AF5F-18A0A1E44D99Q39027669-EAF69EAD-0C5A-4106-A713-E2F2738FCB36Q39285381-A50FCB96-4332-4E4E-B1DF-8C9AC7092405Q39450590-A21B8183-0EE4-4F3A-8C1A-0BC8EF2C53D0Q41908176-F552E928-8974-4E4E-A460-B8DA47A3EE5BQ42363257-B20AABF3-15BA-4599-B6E1-61EFEAC3FF43Q43076075-0920C888-A46D-4C6C-96E5-982A0CD6B837Q46186133-20E85E10-B277-47DC-A937-52805D456C10Q46277748-ACF13E50-1693-4C07-B6FD-965AFCB0CFDCQ47119892-B97C2309-2E59-46AF-86F0-FD3481D97165Q47852970-312DE8CA-CA55-46B3-96F2-EC5439E52142Q47878088-582991D5-E57D-4018-9068-1A2E07643ED3Q48601983-ABEFF4FC-D833-4A04-A84E-D16AEC253484Q48694992-9F20E07E-C844-4755-9938-FD2F1E7D350EQ49384858-2021D714-D4C1-458B-9E4D-1DC547830A60Q54325496-1785E35F-C0D4-498E-9F6E-65EBDA90F4DEQ55094909-45E7CD21-5BDE-472A-BFFD-1E901A41F521Q57462886-7F6E49AF-0C5B-468C-A119-CCF07C33DA80
P2860
Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blockade of Toll-like receptor ...... lieving properties of morphine
@en
Blockade of Toll-like receptor ...... ieving properties of morphine.
@nl
type
label
Blockade of Toll-like receptor ...... lieving properties of morphine
@en
Blockade of Toll-like receptor ...... ieving properties of morphine.
@nl
prefLabel
Blockade of Toll-like receptor ...... lieving properties of morphine
@en
Blockade of Toll-like receptor ...... ieving properties of morphine.
@nl
P2860
P1476
Blockade of Toll-like receptor ...... lieving properties of morphine
@en
P2093
Anne Z Murphy
Lori N Eidson
P2860
P304
15952-15963
P356
10.1523/JNEUROSCI.1609-13.2013
P407
P577
2013-10-01T00:00:00Z